BOC Sciences offers Glycan Biomarker Discovery services for biotech companies, pharmaceutical developers, and research institutions. Our glycomics, glycoproteomics, and bioinformatics expertise support a complete and robust portfolio of analytical and translational services to deliver the highest confidence and clinical relevance for disease-associated glycan signatures. Our Glycan Biomarker Discovery Services support early disease detection, drug development, therapeutic monitoring, and precision medicine applications. From high-resolution LC-MS/MS glycan profiling to artificial intelligence-based data analysis, we work with you to design the right solution for your needs. Our data is biomarker validated and translational ready.
Traditional biomarker discovery often overlooks the complexity of glycosylation, a critical biological process linked to cancer, autoimmune disorders, infectious diseases, and therapeutic response. Our Glycan Biomarker Discovery services are designed to solve key challenges, including:
Early disease detection: uncovering subtle glycan signatures that appear before conventional biomarkers.
Improved diagnostic accuracy: distinguishing between disease subtypes or stages with higher specificity.
Therapeutic monitoring: tracking glycan changes to evaluate treatment efficacy.
Drug development bottlenecks: providing glyco-profiling insights to enhance biopharmaceutical quality, safety, and regulatory compliance.
Data complexity: simplifying high-dimensional glycomics data with advanced computational pipelines and machine learning.
By addressing these issues, we help healthcare companies, research institutions, and biotech startups accelerate breakthroughs with reliable, glycan-based insights.
We ensure high-quality, reproducible sample processing to preserve glycan integrity and maximize discovery potential.
Our robust methods capture the complexity of glycosylation with high sensitivity and accuracy.
We provide state-of-the-art analytical platforms for precise glycan identification and quantification.
We offer high-throughput tools to study glycan-protein interactions and biomarker screening.
We turn complex glycomics data into actionable insights with AI-driven analytics.
By partnering with us, you gain access to unique strengths that set our Glycan Biomarker Discovery services apart.
Comprehensive End-to-End Solution: From initial consultation to clinical translation, we provide full coverage in a single service pipeline.
Cutting-Edge Technology: High-resolution LC-MS/MS, UHPLC, and AI-powered bioinformatics ensure accuracy, sensitivity, and reproducibility.
Expert Glycoscience Team: Our multidisciplinary experts in glycomics, proteomics, and bioinformatics bring deep domain knowledge to every project.
Customized & Scalable: Flexible service modules adapt to small discovery studies or large validation projects.
Accelerated Timelines: Optimized workflows reduce turnaround time, helping you move faster from discovery to market.
We follow a streamlined and standardized workflow to ensure every Glycan Biomarker Discovery project is scientifically rigorous and commercially viable.
We begin with in-depth discussions to understand your research goals or product development pipeline, and design a customized study plan.
Biological samples are processed using optimized workflows to preserve glycan integrity and reduce background interference.
Advanced technologies such as LC-MS/MS, HPLC, and glycan microarrays are applied to generate high-resolution glycomics data.
AI-driven software and specialized glycan databases are used for structural assignment, statistical analysis, and biomarker discovery.
Candidate biomarkers are validated in extended cohorts, and a comprehensive report with actionable insights is delivered.
It is the process of identifying disease-associated glycan structures or glycoproteins that can be used as diagnostic, prognostic, or therapeutic biomarkers.
We work with serum, plasma, urine, tissue, cell lines, and purified proteins, with optimized workflows tailored to each sample type.
We employ LC-MS/MS, UHPLC, HPLC, glycan microarrays, and AI-powered bioinformatics for comprehensive glycomics profiling.
Our services are designed for pharmaceutical companies, biotech startups and academic researchers seeking to accelerate biomarker discovery.
Ready to transform your research or product pipeline with glycan biomarker discovery? At BOC Sciences, we not only deliver world-class analytical and bioinformatics services, but also provide access to a wide range of specific glycans for research and development. Our portfolio includes N-linked glycans, O-linked glycans, sialylated glycans, fucosylated glycans, mannose-rich glycans, and hybrid/complex glycan structures, available for customized analysis and validation. Whether you are in oncology, immunology, infectious disease, or biopharma development, our team is here to help you accelerate discovery, validate biomarkers, and bring glycan-driven solutions closer to clinical and commercial impact.
Contact us today to discuss your project and explore how our Glycan Biomarker Discovery services can empower your next breakthrough.
